Navigation Links
Vinomis Laboratories Launches Vindurance Challenge to Substantiate Claims of Enhanced Physical Endurance with Use of Resveratrol and Quercetin
Date:6/14/2011

SEWICKLEY, Pa., June 14, 2011 /PRNewswire/ -- The benefits of resveratrol are well studied and documented in controlled scientific studies.  It has been shown to slow down the aging process and help prevent age-related diseases including heart disease, cancer, Alzheimer's, diabetes, and others.  But to what extent are benefits being measurably realized by real people incorporating it into their daily lives? After receiving numerous customers' comments claiming enhanced athletic performance, higher energy levels and increased endurance and strength, Vinomis Laboratories has decided to put resveratrol to the test.

The company is recruiting 100 amateur athletes, comprised of runners, swimmers and cyclists, to participate in a 30-day trial to determine if the combination of resveratrol and quercetin produces measureable results of enhanced athletic performance.   Vinomis is using the resveratrol formulation as found in Vindure 900 dietary supplement.   Athletes interested in participating may get more information at www.vindurance.com.

The Vindure 900 formulation is based on discoveries and technology developed at Harvard Medical School and other renowned research institutions, which established the connection between red wine compounds and improved health and longevity in laboratory animals.

These red wine compounds have been shown in numerous laboratory tests to activate the "SIRT" genes which play a key role in slowing down the aging process and protecting the body from many of the adverse effects of aging.

The qualified participants will be required to be between the ages of 30 and 70 years, have a minimum of five years experience in their sport, must already be documenting their performance, and be in good health.  Cyclists must also use a bike computer to ensure accurate tabulation.  Cyclists will track mileage, duratio
'/>"/>

SOURCE Vinomis Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
2. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
3. MO BIO Laboratories, Inc. Launches the PowerWater® Sterivex™ DNA Isolation Kit
4. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist
5. BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases
6. BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
7. Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians
8. Pharmatek Laboratories Adds Spray Drying to Drug Development Services
9. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
10. Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial
11. Analytical Bio-Chemistry (ABC) Laboratories Implements eStudy™ Hosted Platform to Support its Ecotoxicology and Other Service Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... and STOCKHOLM , Dec. 22, 2014 ... partner Auxilium Pharmaceuticals, Inc. today announced that the Committee ... European Medicines Agency (EMA) has adopted a positive opinion ... the treatment of adult men with Peyronie,s disease with ... 30 degrees at the start of therapy. ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
(Date:12/22/2014)... 2014  Pfenex Inc. (NYSE MKT: PFNX) today announced ... been filed and is now open and that this ... of Health and Human Services (HHS), through the Biomedical ... are extremely pleased to have the IND now active ... significant milestone in our company,s partnership with BARDA as ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3
... 2008 ,Boston Scientific Corporation (NYSE: BSX ) ... from its TAXUS IV and TAXUS V randomized,clinical ... of the,TAXUS(R) Express(TM) Paclitaxel-Eluting Coronary Stent System in ... known,increased rates of mortality and restenosis for diabetics ...
... significant reductions in HCV RNA observed; well tolerated in ... all dose cohorts -, ... - Conference call and webcast today at 8:30 ... ITMN ) today provided an overall program update and reported,the top-line results from ...
Cached Medicine Technology:TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials 2TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials 3TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials 4TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials 5InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update 2InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update 3InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update 4InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update 5
(Date:12/22/2014)... Explorys, the leader in big data-driven ... team: Greg Yarrington as Vice President of Operations, Adam ... as Vice President of Solutions. These new leaders are ... in 2015 to support client demand for the company’s ... and growth of its partner network. , Since ...
(Date:12/22/2014)... 22, 2014 Pasadena sleep apnea ... for sleep apnea. Drowsy drivers are 15 times more ... are well-rested, and some experts believe that sleep-deprived drivers ... intoxicated drivers. Unfortunately, millions of Americans may be sleep-deprived ... of Sleep Medicine, about 18 million Americans have sleep ...
(Date:12/22/2014)... Christmas is days away, and last minute ... easy solution that will please: the Sublime Gift Card ... from $25 up to $350," says Kathy Heshelow, founder of ... a wide array of skin care products and Skin Brushes." ... dates. , Gift delivery past shipping deadlines, or those ...
(Date:12/22/2014)... At the annual National ... in San Antonio, esteemed experts and thought leaders ... stand in the way of successful organizational performance: ... premier faculty development opportunity is made possible through ... is to assist nurse educators to advance to ...
(Date:12/21/2014)... offers a wide range of women’s dresses, fashionable accessories ... BellasDress Christmas Sale , offering big discounts on all ... a famous online supplier of women’s dresses; it always ... promotions. The dress experts of the company provide professional ... of offering high quality wedding dresses and women’s special ...
Breaking Medicine News(10 mins):Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:BellasDress.com Announces its BellasDress Christmas Sale 2
... 30 Thoratec,Corporation (Nasdaq: THOR ), a ... today that the FDA Circulatory System Devices,Advisory Panel ... the company,s PMA (PreMarket Approval) allowing the use ... as a,bridge-to-transplantation (BTT)., The HeartMate II is ...
... Families with Deployed Service Members ... ... to Operation Cares, which supports the needs of the,more than 4,000 of South ... the central market area at,TriWest, will present the check to Steve Doohen, secretary ...
... cell agency is inviting for-profit companies to apply ... for Taxpayer and Consumer Rights,(FTCR) noted today and ... the awards process to prevent abuse., The ... calls for applications for two types of grants. ...
... following is a,statement from Henrietta H. Fore, USAID ... again recognizes World AIDS,Day and the more than ... Through the President,s Emergency Plan for AIDS Relief ... supporting those,battling the disease, as well as those ...
... ALEXANDRIA, Va., Nov. 30 The Pharmaceutical,Care ... falsely claiming,that pending legislation requiring prompt payment ... cost billions of dollars. PCMA represents 10,pharmacy ... administer,prescription drug plans. In response, Bruce Roberts, ...
... Neurochem Inc. (NASDAQ:,NRMX; TSX: NRM) today announces the ... Business. Dr. Calais joined Neurochem,in 2003, and is ... "Dr. Calais has made a significant contribution ... and we,are grateful for having had the benefit ...
Cached Medicine News:Health News:Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation 2Health News:Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation 3Health News:TriWest Contributes $10,000 to Operation Cares for South Dakota's Military Families 2Health News:Close Scrutiny Needed as First Stem Cell Grants Offered to For-Profit Companies, Consumers Say 2Health News:On World AIDS Day, Keeping the Promise to Stop AIDS Through the Power of Partnerships 2Health News:NCPA Statement on Bogus PCMA Study About Cost to Fix Medicare Part D 2Health News:Neurochem announces departure of Dr. Philippe Calais, President, Global Business 2
This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....
All New Ultra Pb Series Glasses...
... eye protection Properly manufactured radiation protective ... radiation. Our high quality frames and materials ... minimized weight. Our lenses are made of ... all industry standards. Most Pulse Glasses are ...
... Stylish and comfortable eye protection ... approximately 90% of scatter radiation. Our high ... protection and comfort with minimized weight. Our ... leaded) optics that meet all industry standards. ...
Medicine Products: